BIRC5 and nonpapillary renal cell carcinoma: Early studies on the expression of survivin (also called BIRC5) indicated that survivin expression is an independent predictor of clear cell RCC (ccRCC) progression and death and may provide a novel target for the development of new adjuvant therapies [22].